Published on 16 May 2024 on Simply Wall St. via Yahoo Finance
ANI Pharmaceuticals, Inc. Just Beat EPS By 459%: Here's What Analysts Think Will Happen Next
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) just released its quarterly report and things are looking bullish. The company beat forecasts, with revenue of US$137m, some 9.0% above estimates, and statutory earnings per share (EPS) coming in at US$0.82, 459% ahead of expectations. Earnings are an important time for investors, as they can track a company's performance, look at what the analysts are forecasting for next year, and see if there's been a change in sentiment towards the company. With this in mind, we've gathered the latest statutory forecasts to see what the analysts are expecting for next year.
See our latest analysis for ANI Pharmaceuticals
